From Device Centric To Disease Management: Ascensia Commits To Deeper Role In Diabetes
Executive Summary
Ascensia is pushing back the borders of diabetes control, using its legacy BGM technology as a business platform to move into CGM en route to becoming a one-stop-shop for diabetes management solutions. A significant step toward these goals was taken in January, when the Swiss group completed a key China deal with a local CGM innovator, as chief marketing and strategy officer Martin Lange explained to In Vivo.
You may also be interested in...
UK Government Promise For 2021: No Halting The Advance Of Healthtech Innovation Adoption
There can be no such thing as a COVID dividend, but the renewed digital push and momentum for health system change perhaps come closest.
UK Medtechs Determined To Exploit Digital Health Opportunity Born From The Pandemic
COVID-19 has forced a rethink in how care should be delivered. Healthcomms Consulting partner Dan Jones says it is an opportunity that must not be squandered.
UK Device Safety To Be Enhanced By Patient Safety Commissioner
Certain Cumberlege Review recommendations are making their way into draft UK legislation as the government presses ahead in shaping the UK’s post-Brexit devices regulatory system.
Need a specific report? 1000+ reports available
Buy Reports